TrialPloS one2018

Cost-effectiveness analysis of capecitabine monotherapy versus capecitabine plus oxaliplatin in elderly patients with advanced gastric cancer.

Jingyuan Peng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.